BRIEF-Supernus Pharmaceuticals Q4 Product Sales USD 166.4 Million

Reuters
26 Feb
BRIEF-<a href="https://laohu8.com/S/SUPN">Supernus Pharmaceuticals</a> Q4 Product Sales USD 166.4 Million

Feb 25 (Reuters) - Supernus Pharmaceuticals Q4 operating earnings USD 21.405 million.

  • Q4 adjusted revenue USD 146.2 million vs. IBES estimate USD 155.3 million
  • outlook FY revenue USD 600-630 million
  • outlook FY adjusted operating earnings USD 105-130 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10